Pharma Marketing Network

This survey solicits your opinion on how effective Twitter can be in carrying out patient support activities/communications.

Results of a 2008 Harris Interactive poll of American attitudes toward corporate America revealed that only 26 percent of Americans view the pharmaceutical industry industry favorably. 52 percent are firmly negative, which places pharma slightly below big oil, and above tobacco. Is the drug industry's bad reputation is deserved? What are the specific reasons why the public has such low esteem for the industry? Take our survey and tell us what you think the industry should do to improve its public image.

The distinction between pharma brand managers and corporate communications is a distinction without much of a difference these days, especially with regard to social media. There are many

As more and more pharmaceutical companies launch social networking platforms associated with their brands, some will allow users (consumers, patients, and physicians) to post comments as part of ongoing discussions about drugs and/or the conditions they treat. Recent pharma experience with social media discussions demonstrate how important it is to properly manage online communities. Perhaps the most important management tool is moderation.

By filling out the Pharma Marketing News Rate Your Social Media Marketing Readiness online questionnaire, you will discover where you may need to augment your knowledge about social media and what internal regulatory and cultural hurdles you may need to overcome to implement a social media marketing program.

This survey is designed to inform the discussion on the pros and cons of how Social, Mobile, & Gaming Technologies technologies drive patient engagement and what value they have in solving the long-standing medication adherence problem.

Before you find yourself in a social media crisis, you should have a social media implementation plan. But what are the action items for implementing your plan? This survey presents a number of actions that may be appropriate and seeks your input on how important these or other items might be in developing a plan.

This survey asks your opinion on whether or not paid inclusion should be used by pharmaceutical marketers and under what conditions.

Please take 2 minutes to answer a few short questions relating to the FDA's Revised Draft Guidance for Industry on Distributing Scientific and Medical Publications on Unapproved New Uses—Recommended Practices.

This survey asks your opinion about Pharma's use of redirect (aka 'vanity') URLS in paid search engine ads.